SCHOTT Pharma AG & Co. KGaA (FRA:1SXP)

Germany flag Germany · Delayed Price · Currency is EUR
15.06
-0.14 (-0.92%)
Apr 24, 2026, 10:31 AM CET
Market Cap2.29B -24.0%
Revenue (ttm)995.03M +4.1%
Net Income149.95M +11.1%
EPS0.99 +10.0%
Shares Outn/a
PE Ratio15.27
Forward PE15.63
Dividend0.18 (1.16%)
Ex-Dividend DateFeb 4, 2026
Volume2,200
Average Volume182
Open15.22
Previous Close15.20
Day's Range15.06 - 15.22
52-Week Range12.68 - 30.10
Betan/a
RSI60.67
Earnings DateMay 13, 2026

About FRA:1SXP

SCHOTT Pharma AG & Co. KGaA develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide. The company offers syriQ, a glass syringe for vaccines; syriQ BioPure, a glass syringe for biologics; syriQ BioPure silicone-free, a prefillable and silicone-free glass syringe for biologics; SCHOTT TOPPAC, a polymer syringe; SCHOTT TOPPAC cosmetic, a polymer syringe for aesthetic treatments; SCHOTT TOPPAC freeze, a polymer syringe for deep-cold application... [Read more]

Sector Healthcare
Founded 1884
Employees 4,829
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 1SXP

Financial Performance

In fiscal year 2025, FRA:1SXP's revenue was 986.21 million, an increase of 3.04% compared to the previous year's 957.09 million. Earnings were 146.45 million, a decrease of -2.16%.

Financial Statements